"The US Food and Drug Administration (FDA) has approved a fixed-dose combination of memantine hydrochloride extended-release (XR) and donepezil hydrochloride (Namzaric, Actavis plc/Adamas Pharm) for moderate to severe Alzheimer's-related de"...
Serious Skin Reactions
Advise patients and caregivers to discontinue RAZADYNE® ER or RAZADYNE® and seek immediate medical attention at the first appearance of skin rash [see WARNINGS AND PRECAUTIONS].
General Dosing Guidance
Instruct caregivers about the recommended dosage and administration of RAZADYNE® ER and RAZADYNE®. RAZADYNE® ER extended-release capsules should be administered once daily in the morning, preferably with food. RAZADYNE® tablets and oral solution should be administered twice per day, preferably with the morning and evening meals. Dose escalation (dose increases) should follow a minimum of four weeks at prior dose. If therapy has been interrupted for more than three days, the patient should be restarted with the lowest dose and then re-titrated to an appropriate dosage [see DOSAGE AND ADMINISTRATION].
Advise patients and caregivers to ensure adequate fluid intake during treatment [see DOSAGE AND ADMINISTRATION].
Advise patients and caregivers that the most frequent adverse events associated with use of the drug can be minimized by following the recommended dosage and administration.
Oral Solution Instruction Sheet
Instruct caregivers in the correct procedure for administering RAZADYNE® oral solution. In addition, inform them of the existence of an Instruction Sheet (included with the product) describing how the solution is to be administered. Urge caregivers to read this sheet prior to administering RAZADYNE® oral solution, and to direct questions about the administration of the solution to either their physician or pharmacist.
Last reviewed on RxList: 12/28/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Razadyne ER Information
Razadyne ER - User Reviews
Razadyne ER User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.